A recent report published by Infinium Global Research on proton therapy market provides in-depth analysis of segments and sub-segments in the global as well as regional proton therapy market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional proton therapy market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global proton therapy market. According to the report, the global proton therapy market is expected to reach USD 1820 million in 2026, with a CAGR of 6.34% during the forecast period 2020-2026.

Market Insight

Proton therapy also recognized as proton radiotherapy, usages high-energy beams to treat tumors. The approach includes depositing a precision dose of high energy radiation in the target tumor. It is extensively used in the treatment of cancer. Furthermore, protons scatter less than other forms of x-ray radiation, thus safeguarding less damage to the surrounding healthy tissues. Moreover, proton therapy is used as a combination therapy with other treatment methods. It offers numerous advantages such as precise targeting of tumors and cancer cells, minimal exit dose, condensed overall toxicity. Rising funding for cancer research is anticipated to offer lucrative growth opportunities for players in the proton therapy market. Additionally, the increasing number of healthcare facilities offering proton therapy is also projected to aid in the growth of the market during the forecast period.

The global proton therapy market is mainly driven by snowballing healthcare expenditure and growing preference for advanced therapies by healthcare physicians. The increasing prevalence of cancer is anticipated to propel the growth of the global proton therapy market over the projection period. For example, as stated by the World Health Organization (WHO), around 18.1 million new cases, and 9.6 million deaths were registered due to cancer across the world in the year 2018. On the other hand, pricing can become restraining in the global proton therapy market, particularly when it comes to the affordability of proton beam therapy devices by small hospital setups. However, the introduction of proton therapy in developing economies is estimated to offer lucrative growth opportunities for players in the market. In addition, the development of compact machines is also projected to aid in the growth of the proton therapy market.  Proton therapy devices presently available in the market involve a large area for setting up. Thus, market players can focus on sinking the size of all the parts in proton therapy devices. 

Additionally, the current concern over the spread of coronavirus is also projected to have a negative impact on the proton therapy market for the short term. Various countries have initiated lockdowns and enforced nationwide travel and trade restrictions. Further, the COVID-19 outburst has impacted virtually every aspect of cancer care and research, from introducing novel risks for cancer patients to troubling the delivery of cancer treatment and the steadiness of cancer research. The main factors expected to exert an impact on the proton therapy market include delay in outpatient hospital visits for treatments, reduced healthcare spending, and delay in approval and launch of new treatment therapies. The novel coronavirus is reshaping clinical trials and delivery of cancer care broadly, and these changes might tolerate well beyond the short- to mid-term of the active epidemic.

Among the geographies, the North America region is expected to hold the largest share in the global proton therapy market owing to a surge in funding for the research & development and healthcare infrastructure. Further, factors such as an increase in the incidence of several cancers such as stomach, lung, liver, colorectum, and esophagus are driving the proton therapy market in the North America region. Furthermore, the Asia Pacific region is projected to witness the fastest growth in the proton therapy market during the forecast period owing to the rising healthcare infrastructure. In addition, the rising awareness about the advanced treatment procedures and increasing demand for healthcare facilities in emerging economies such as China and India drive the proton therapy market in this region.

Segment Covered

The report on global proton therapy market covers segments such as system type, application, and end use. On the basis of system type, the sub-markets include single room systems, and multi room systems. On the basis of application, the sub-markets include prostate cancer, lung cancer, colorectal cancer, pediatric cancer, and others. On the basis of end use, the sub-markets include hospitals, ambulatory surgical centers, and specialty clinics.

Companies Profiled:

The report provides profiles of the companies in the market such as Hitachi Ltd., Ion Beam Applications SA, Mevion Medical Systems, Mitsubishi Electric Corporation, ProNova Solutions, LLC, ProTom International, Sumitomo Heavy Industries Ltd., Optivus Proton Therapy, Inc., Advanced Oncotherapy plc, and Varian Medical Systems, Inc.

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of proton therapy market. Moreover, the study highlights current market trends and provides forecast from 2020-2026. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.